Meyers James R
SEC-identified person · CIK 1387521 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Cytomx Therapeutics, Inc. CTMX | Director | filed 2018 - 2026 |
| Vera Therapeutics, Inc. VERA | Director | filed 2025 - 2026 |
| Sangamo Therapeutics, INC SGMO | Director | filed 2019 - 2025 |
| Tekmira Pharmaceuticals Corp TKMR | Director | filed 2018 - 2024 |
| Gilead Sciences, INC. GILD | SVP Comm Ops North America | filed 2007 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.